
1. lancet. 1981 feb 7;1(8215):289-92.

efficacy hepatitis b vaccine prevention early hbsag carrier state in
children. controlled trial endemic area (senegal).

maupas p, chiron jp, barin f, coursaget p, goudeau a, perrin j, denis f, mar id.

three doses inactivated hepatitis b vaccine given one-month intervals 
to senegalese children aged less two years. control group received
diphtheria/tetanus/polio vaccine. hb vaccine recipients were
seronegative immunisation, 94.5% specific anti-hbs response.
anti-hbs maternal origin interfere active immunisation. hb
vaccine without ill-effects, irrespective hepatitis b marker status before
immunisation. twelve months' follow-up, incidence hbsag carrier 
state reduced 85% susceptible children (p less 0.0001).

doi: 10.1016/s0140-6736(81)91908-5 
pmid: 6109938  [indexed medline]

